Early recognition of Duchenne muscular dystrophy: where could we improve?
نویسندگان
چکیده
Background: Duchenne muscular dystrophy (DMD) is caused by a mutation in the dystrophin gene and most common form of childhood-onset affecting approximately 1 3500 newborn boys. The disease invariably progressive patients with DMD exhibit signs muscle weakness before 5 years age. Loss ability to walk usually occurs between 10 13 years. Despite all advances management treatment over last decades, mean age at diagnosis has been reported be around 4.5-5 several countries delay about 2 first symptoms are noted, diagnosis.
منابع مشابه
Exercise and Duchenne muscular dystrophy: where we have been and where we need to go.
EXERCISE AND DUCHENNE MUSCULAR DYSTROPHY: WHERE WE HAVE BEEN AND WHERE WE NEED TO GO CHAD D. MARKERT, PhD, LAURA E. CASE, DPT, PCS, GREGORY T. CARTER, MD, MS, PATRICIA A. FURLONG, RN, BSN, MS, and ROBERT W. GRANGE, PhD Wake Forest Institute for Regenerative Medicine, Wake Forest University, Winston-Salem, North Carolina 27157, USA Division of Physical Therapy, Department of Community and Family...
متن کاملDuchenne muscular dystrophy An overview of Duchenne muscular dystrophy
Duchenne muscular dystrophy (DMD) affects approximately 1 in 3,500 live male births [1]. It is caused by a large variety of mutations in the dystrophin gene. Because of these mutations, the body can no longer make dystrophin which is a protein important for stabilisation of the muscle cell during a contraction. Without dystrophin, muscle cells are damaged and slowly replaced by fat and scar tis...
متن کاملEarly prednisone treatment in Duchenne muscular dystrophy.
The purpose of this long-term, open parallel-group, double-consent study of alternate-day, low-dose prednisone in 2-4-year-old patients with Duchenne muscular dystrophy (DMD) was to determine whether prednisone produces a beneficial effect when given earlier than usual. Muscle function was evaluated by timed tests, and muscle strength with a hand-held myometer. After 55 months of treatment, the...
متن کاملEarly observations on duchenne-meryon muscular dystrophy.
cles, loss of ambulation by adolescence, and early death. His harpoon muscle biopsies established the loss of muscle fi bre striation, hyperplasia of fi brous connective tissue with replacement by granular matter and fat vesicles, and fascicular atrophy of the muscles and destruction of the muscle as essential features. Duchenne wrote [4] : ‘This disease is mainly characterised: (1) By feeblene...
متن کاملP164: Adeno-Associated Viral Vectors in Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (BMD) is an inherited X-link disease. The incidence of this muscle-wasting disease is 1:5000 male live births. Mutation in the gene coding for dystrophin is the main cause of BMD. Most cases of this disease succumb to respiratory and cardiac failure in 3rd to 4th decades. The slow progression of BMD and recent achievement of gene therapies make it as an appropriate c...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Arquivos De Neuro-psiquiatria
سال: 2023
ISSN: ['1678-4227', '0004-282X']
DOI: https://doi.org/10.1055/s-0043-1774421